These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3495748)

  • 21. Normal pattern of labeling of cerebral cortical corticotropin-releasing factor (CRF) receptors in Alzheimer's disease: evidence from chemical cross-linking studies.
    Grigoriadis DE; Struble RG; Price DL; De Souza EB
    Neuropharmacology; 1989 Jul; 28(7):761-4. PubMed ID: 2548115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progressive supranuclear palsy affects both the substantia nigra pars compacta and reticulata.
    Hardman CD; Halliday GM; McRitchie DA; Cartwright HR; Morris JG
    Exp Neurol; 1997 Mar; 144(1):183-92. PubMed ID: 9126169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Corticotropin-releasing factor-like immunoreactivity in senile dementia of the Alzheimer type. Reduced cortical and striatal concentrations.
    Bissette G; Reynolds GP; Kilts CD; Widerlöv E; Nemeroff CB
    JAMA; 1985 Dec; 254(21):3067-9. PubMed ID: 3877182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Filamentous aggregates in Pick's disease, progressive supranuclear palsy, and Alzheimer's disease share antigenic determinants with microtubule-associated protein, tau.
    Pollock NJ; Mirra SS; Binder LI; Hansen LA; Wood JG
    Lancet; 1986 Nov; 2(8517):1211. PubMed ID: 2430155
    [No Abstract]   [Full Text] [Related]  

  • 25. Induction of immune system mediators in the hippocampal formation in Alzheimer's and Parkinson's diseases: selective effects on specific interleukins and interleukin receptors.
    Araujo DM; Lapchak PA
    Neuroscience; 1994 Aug; 61(4):745-54. PubMed ID: 7838374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frontal deficits differentiate progressive supranuclear palsy from Parkinson's disease.
    Lee YE; Williams DR; Anderson JF
    J Neuropsychol; 2016 Mar; 10(1):1-14. PubMed ID: 25223526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Binding of [125I]corticotropin releasing factor to blood immunocytes and its reduction in Alzheimer's disease.
    Singh VK; Fudenberg HH
    Immunol Lett; 1988 May; 18(1):5-8. PubMed ID: 2837436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progressive supranuclear palsy: loss of choline-acetyltransferase-like immunoreactive neurons in the pontine reticular formation.
    Malessa S; Hirsch EC; Cervera P; Javoy-Agid F; Duyckaerts C; Hauw JJ; Agid Y
    Neurology; 1991 Oct; 41(10):1593-7. PubMed ID: 1922800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spinal fluid CRF reduction in Alzheimer's disease.
    Mouradian MM; Farah JM; Mohr E; Fabbrini G; O'Donohue TL; Chase TN
    Neuropeptides; 1986; 8(4):393-400. PubMed ID: 3493444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and cognitive correlations of regional gray matter atrophy in progressive supranuclear palsy.
    Giordano A; Tessitore A; Corbo D; Cirillo G; de Micco R; Russo A; Liguori S; Cirillo M; Esposito F; Tedeschi G
    Parkinsonism Relat Disord; 2013 Jun; 19(6):590-4. PubMed ID: 23477861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of CRH in the pathogenesis of dementia of Alzheimer's type and other dementias.
    Rehman HU
    Curr Opin Investig Drugs; 2002 Nov; 3(11):1637-42. PubMed ID: 12476966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decrease of serotonin-S2 receptors in temporal cortex of patients with Parkinson's disease and progressive supranuclear palsy.
    Maloteaux JM; Laterre EC; Laduron PM; Javoy-Agid F; Agid Y
    Mov Disord; 1988; 3(3):255-62. PubMed ID: 3193963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia.
    Chan-Palay V
    J Comp Neurol; 1988 Jul; 273(4):543-57. PubMed ID: 2463283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accuracy of MR markers for differentiating Progressive Supranuclear Palsy from Parkinson's disease.
    Zanigni S; Calandra-Buonaura G; Manners DN; Testa C; Gibertoni D; Evangelisti S; Sambati L; Guarino M; De Massis P; Gramegna LL; Bianchini C; Rucci P; Cortelli P; Lodi R; Tonon C
    Neuroimage Clin; 2016; 11():736-742. PubMed ID: 27330973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Positron emission tomography imaging of tau pathology in progressive supranuclear palsy.
    Coakeley S; Cho SS; Koshimori Y; Rusjan P; Harris M; Ghadery C; Kim J; Lang AE; Wilson A; Houle S; Strafella AP
    J Cereb Blood Flow Metab; 2017 Sep; 37(9):3150-3160. PubMed ID: 28155586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropeptides in Alzheimer's disease: a postmortem study.
    Nemeroff CB; Kizer JS; Reynolds GP; Bissette G
    Regul Pept; 1989 Apr; 25(1):123-30. PubMed ID: 2566190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Corticotropin-releasing factor immunoreactivity in monkey neocortex: an immunohistochemical analysis.
    Lewis DA; Foote SL; Cha CI
    J Comp Neurol; 1989 Dec; 290(4):599-613. PubMed ID: 2613945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cholinergic cortical circuits in Parkinson's disease and in progressive supranuclear palsy: a transcranial magnetic stimulation study.
    Nardone R; Florio I; Lochner P; Tezzon F
    Exp Brain Res; 2005 May; 163(1):128-31. PubMed ID: 15754175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholinergic imaging in corticobasal syndrome, progressive supranuclear palsy and frontotemporal dementia.
    Hirano S; Shinotoh H; Shimada H; Aotsuka A; Tanaka N; Ota T; Sato K; Ito H; Kuwabara S; Fukushi K; Irie T; Suhara T
    Brain; 2010 Jul; 133(Pt 7):2058-68. PubMed ID: 20558417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of degeneration in motor thalamus and cortex between progressive supranuclear palsy and Parkinson's disease.
    Halliday GM; Macdonald V; Henderson JM
    Brain; 2005 Oct; 128(Pt 10):2272-80. PubMed ID: 16014651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.